Share article:
Share article:

GSK-Sanofi delay Covid-19 vaccine due to setback

© Belga

The coronavirus vaccine being developed by GSK-Sanofi will not be ready before late 2021 after the pharma firms announced a delay due to unsatisfactory results in elderly patients.

The companies said they were expecting to have the vaccine ready in late 2021 after they announced a setback in the immune responses observed in older adults participating in their clinical trials.

In an online statement, Sanofi said that the interim trial results had shown an immune response “comparable to patients who have recovered from Covid-19” in adults aged 18 to 49, but “a low immune response in older adults.”

Related News:

 

The British pharma firm said that the underperforming results in older adults could be “likely due to an insufficient concentration of the antigen,” a substance which triggers the production of antibodies by the immune system.

“The results of the study are not as we hoped,” GSK Vaccines President Roger Connor said, adding that he was “confident” in the companies’ ability to produce a Covid-19 vaccine which “can elicit a robust immune response.”

The companies said they would aim to “refine the concentration of antigen in order to provide high-level immune response across all age groups” and that they were expecting to kick off a new phase of clinical trials in February “with an improved antigen formulation.”

The study in question involved a total of 441 healthy adults in 10 locations in the United States, who were given two doses of the candidate vaccine or a placebo at 21 days apart.

The companies said that no participant developed any serious adverse effects during the study.

GSK-Sanofi’s announcement comes as several countries gear up to launch their mass vaccination campaigns against the coronavirus, after the UK began its massive vaccination effort this week, following approval of the Pfizer/BioNTech jab.

Pending approval from the EU’s drug regulator, Belgium said it is ready to begin vaccinating people in priority groups as early as 5 January.

Under current arrangements, Belgium is currently set to receive over 20 million vaccine doses from a range of manufacturers. It had not yet been decided whether it would subscribe to the GSK-Sanofi jab.

Gabriela Galindo
The Brussels Times

Latest news

Increase in number of people ‘asking King for mercy’ through royal pardons
More and more people living in Belgium have been seeking royal pardons, mainly for fines, largely as a result of it now being possible to send in ...
England now accepting cheaper Covid tests from fully vaccinated travellers
Fully vaccinated travellers who enter England from non-red countries will only be required to book a lateral flow test to take following their ...
Re-introducing face masks indoors considered as Covid-19 situation worsens
Belgium's council of ministers will hold an emergency meeting on Monday to discuss the worsening epidemiological situation, and reintroducing face ...
Federal museums to receive €2.9 million booster shot
Federal museums will receive an additional €2.9 million in support from the government for the fiscal year 2021, of which the first payouts will be ...
European Parliament emphasises healthy food and animal welfare in EU Farm to Fork Strategy
The European Parliament adopted this week a resolution on the EU Farm to Fork Strategy calling for a fair, healthy and environmentally-friendly food ...
Threats of strike action could affect Brussels’ STIB network from Monday
Brussels public transport operator STIB's trams, buses and metros could be affected from Monday 25 October onwards as the union representing the ...
Number of international adoptions in Belgium continues to drop
The number of regulated international adoptions authorised by Belgium further dropped in 2020, continuing an ongoing decreasing trend. Last ...
Disaster drill with emergency services held at Brussels Airport
Around 300 people took part in a disaster drill held was organised on Saturday by Brussels Airport in collaboration with external emergency services ...
Austria presents bill to legalise euthanasia
Austria’s government on Saturday presented its proposals for legalising assisted suicide, in response to a Constitutional Court ruling that the ...
Brussels’ Museum Night Fever draws in some 12,000 visitors
Some 12,000 participants took part in the 14th edition of Museum Night Fever in Brussels, with the 29 participating museums filled to the maximum ...
Relaunch of 10,000 steps campaign to get Flemish people moving
The Flemish government is breathing new life into its 10,000 steps campaign to get people in the region moving after a recent survey found that a ...
‘No scientific basis’ for giving everyone third dose, vaccine expert says
The head of Belgium's Vaccination Taskforce has argued that there is not enough scientific evidence to support the Flemish government's decision to ...